- Home
- BKU vs ZLAB Comparison
BKU vs ZLAB Comparison
Compare BKU & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- ZLAB
- Stock Information
- Founded
- BKU 2009
- ZLAB 2013
- Country
- BKU United States
- ZLAB China
- Employees
- BKU N/A
- ZLAB N/A
- Industry
- BKU Savings Institutions
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- BKU Finance
- ZLAB Health Care
- Exchange
- BKU Nasdaq
- ZLAB Nasdaq
- Market Cap
- BKU 2.6B
- ZLAB 3.6B
- IPO Year
- BKU 2011
- ZLAB 2017
- Fundamental
- Price
- BKU $37.26
- ZLAB $32.54
- Analyst Decision
- BKU Hold
- ZLAB Buy
- Analyst Count
- BKU 11
- ZLAB 5
- Target Price
- BKU $40.55
- ZLAB $54.28
- AVG Volume (30 Days)
- BKU 815.5K
- ZLAB 781.8K
- Earning Date
- BKU 07-23-2025
- ZLAB 08-05-2025
- Dividend Yield
- BKU 3.32%
- ZLAB N/A
- EPS Growth
- BKU 38.76
- ZLAB N/A
- EPS
- BKU 3.21
- ZLAB N/A
- Revenue
- BKU $972,198,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- BKU $13.53
- ZLAB $44.07
- Revenue Next Year
- BKU $6.80
- ZLAB $49.13
- P/E Ratio
- BKU $11.64
- ZLAB N/A
- Revenue Growth
- BKU 11.13
- ZLAB 43.72
- 52 Week Low
- BKU $28.21
- ZLAB $16.01
- 52 Week High
- BKU $44.45
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- BKU 61.52
- ZLAB 40.19
- Support Level
- BKU $37.25
- ZLAB $34.26
- Resistance Level
- BKU $38.13
- ZLAB $35.72
- Average True Range (ATR)
- BKU 0.84
- ZLAB 1.12
- MACD
- BKU 0.18
- ZLAB -0.54
- Stochastic Oscillator
- BKU 78.13
- ZLAB 3.83
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.